NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

barcode27 Monday, 01/30/17 03:16:35 PM
Re: None
Post # of 104331
Some recent activity on patent application 20150273033 (COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER). The latest filed document from last Wednesday is a response to the patent office requesting restriction/election, but gives a good baseline of the current claims that the company is making in this area (DCVax + CI therapy).

https://drive.google.com/open?id=0B89PfR-Tr-jCSXdxQTBfMFVvME0

Then ad this:

Patents 4 Patients
We receive approximately 900 cancer immunotherapy applications annually from around the world. This newly established program provides a fast-track review for cancer immunotherapy-related patent applications without the need for an applicant to pay an additional fee. The program, set to launch in July:
Aims to cut the time it takes to review patent applications in cancer therapy in half (final decisions in 12 months or less).
Is open to any applicant, including early stage bio-tech companies, universities and large pharmaceutical firms.
Is open to entities who may have products already in FDA approved clinical trials, allowing them to opt in, even if they have a patent application already filed.
Moves new treatments from conception through regulatory approval swiftly, to reach patients faster.
For more information about our Patents 4 Patients program, please refer to the Federal Register Notice (link is external). -- https://www.uspto.gov/about-us/national-cancer-moonshot

More LP fingerprints....imho.